Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6375 USD | +1.19% | -10.20% | -87.00% |
Mar. 15 | Maxim Group Adjusts Quoin Pharmaceuticals Price Target to $4 From $15, Maintains Buy Rating | MT |
Mar. 14 | Quoin Pharmaceuticals Seeks M&A Opportunities | CI |
Business Summary
Number of employees: 4
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Myers
CEO | Chief Executive Officer | 62 | 18-03-04 |
Denise Carter
FOU | Founder | 55 | 18-03-04 |
Gordon Dunn
DFI | Director of Finance/CFO | 60 | 21-10-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Sember
BRD | Director/Board Member | - | 21-10-27 |
Dennis Langer
BRD | Director/Board Member | 73 | 21-10-27 |
Joseph Cooper
BRD | Director/Board Member | 66 | 21-10-27 |
Director/Board Member | 68 | 21-10-27 | |
Michael Myers
CEO | Chief Executive Officer | 62 | 18-03-04 |
Denise Carter
FOU | Founder | 55 | 18-03-04 |
Natalie Leong
BRD | Director/Board Member | 39 | 21-10-27 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,685,970 | 967,867 ( 26.26 %) | 0 | 26.26 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-87.00% | 2.35M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- QNRX Stock
- Company Quoin Pharmaceuticals, Ltd.